Sens. Warren and Blumenthal ask the FDA and FTC to review Juul’s sponsorship of an entire edition of the American Journal of Health Behavior.
FDA
Posted inCoronavirus
Pfizer’s Bottom Line
As the pharmaceutical company makes a pitch for booster shots, epidemiologists question its motives and worry boosters might stymie global vaccine efforts.
Posted inHealth and Social Policy
Juul: Taking Academic Corruption to a New Level
The e-cigarette company bought an entire issue of a scholarly journal, with all the articles written by authors on its payroll, to ‘prove’ that its product has a public benefit.
Posted inHealth and Social Policy
The Post-COVID Health Care System Is Out of Control
After gouging Americans for record pandemic profits, the health care industry sets its sights on even more.
Posted inFirst 100
First 100: Libertarian Demands for Vaccine Acceleration Curiously Doesn’t Call Out Drug Manufacturers
The motivation seems less like saving lives and more like ideology.
Posted inTAP
COVID Vaccines: The Deep State Wins One
Today on TAP: The FDA will not grant early approvals
Posted inBooks
Monopolies Are Why Salt and Water in a Bag Became a Scarce Item
An excerpt from a new book on life in the age of corporate power
Posted inHealth and Social Policy
The War on Facts Hits Prescription Drug Regulation
The FDA’s authority was under legal attack even before Trump. Now the agency faces a triple threat.
Posted inHealth and Social Policy
Beware Compounded Drugs — Especially Under Trump’s FDA
A burgeoning and little-regulated private industry that specially mixes drugs at so-called compounding pharmacies poses a public-health hazard that the Trump administration is about to make a whole lot worse.
Posted inMoney, Politics, and Power
Cures Act Is Bad Medicine for NIH, FDA
A bipartisan bill that promises more money for research and development is actually full of giveaways for the pharmaceutical industry and other trade groups.